Cloperastina fendizoato

Tussal 35,4 MG Jarabe en Sobres

35,4 mg jarabe en sobreSpainMarketedAuthorised 25 Apr 2024

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
TUSSAL 35,4 MG JARABE EN SOBRES, 20 sobres de 10 ml	764795

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cloperastina fendizoato

Tussal 35,4 MG Jarabe en Sobres

35,4 mg jarabe en sobreSpainMarketedAuthorised 25 Apr 2024

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
TUSSAL 35,4 MG JARABE EN SOBRES, 20 sobres de 10 ml	764795

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cloperastina fendizoato
Strength: 35,4 mg
Dosage form: jarabe en sobre
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 25 Apr 2024
Registration: 89519
Marketing authorisation holder: Kern Pharma S.L.
Procedure: National, MRP or DCP
Supply: Sin Receta

CLOPERASTINA NORMON 3,54 mg/ml SUSPENSION ORALCloperastina fendizoato · 3,54 mg · suspensión oralSpain

FLUTOX 3,54 mg/ml JARABECloperastina fendizoato · 354,00 mg · jarabeSpain

SEKISAN 3,54 mg/ml JARABECloperastina fendizoato · 3,54 mg · jarabeSpain

Alvitatos 3,54 MG/ML JarabeCloperastina fendizoato · 3,54 mg/ml · jarabeSpain

Flutox 17,7 MG Pastillas Para ChuparCloperastina fendizoato · 17,7 mg · pastilla para chuparSpain

Flutox 35,4 MG Pastillas Para ChuparCloperastina fendizoato · 35,40 mg · pastilla para chuparSpain